Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 151

    1.

    Role of renin-angiotensin system blockade in patients with diabetes mellitus.

    Braga MF, Leiter LA.

    Am J Cardiol. 2009 Sep 15;104(6):835-9. Review.PMID: 19733720 [PubMed - indexed for MEDLINE]Related articles

    2.

    Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.

    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA; Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.

    Am J Cardiol. 2009 Sep 15;104(6):798-804. Epub 2009 Jul 23.PMID: 19733714 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hypertension in diabetes: a call to action.

    Campbell NR, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki R.

    Can J Cardiol. 2009 May;25(5):299-302. Review.PMID: 19417860 [PubMed - indexed for MEDLINE]Related articles

    4.

    The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

    Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

    Can J Cardiol. 2009 May;25(5):287-98. Review.PMID: 19417859 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cardiovascular risk and glycemic control.

    Cheng AY, Leiter LA.

    CMAJ. 2009 Apr 28;180(9):907-8. No abstract available. PMID: 19398731 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Recommendations for management of dyslipidemia in high cardiovascular risk patients.

    Braga MB, Langer A, Leiter LA.

    Exp Clin Cardiol. 2008 Summer;13(2):71-4.PMID: 19343119 [PubMed - in process]Related articlesFree article

    7.

    Effect of atorvastatin on circulating hsCRP concentrations: A sub-study of the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study.

    Gensini GF, Gori AM, Dilaghi B, Rostagno C, Gaw A, Blanco-Colio LM, de Teresa E, Egido J, Farsang C, Leiter LA, Martineau P, Nozza A, Langer A; on behalf of the ACTFAST investigators.

    Int J Cardiol. 2009 Feb 11. [Epub ahead of print]PMID: 19217176 [PubMed - as supplied by publisher]Related articles

    8.

    Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?

    Saposnik G, Goodman SG, Leiter LA, Yan RT, Fitchett DH, Bayer NH, Casanova A, Langer A, Yan AT; Vascular Protection; Guidelines-Oriented Approach to Lipid-Lowering Registries Investigators; Stroke Outcome Research Canada Working Group.

    Stroke. 2009 Apr;40(4):1417-24. Epub 2009 Feb 12.PMID: 19213947 [PubMed - indexed for MEDLINE]Related articles

    9.

    Diabetes and cardiovascular disease: the role of glycemic control.

    Cheng AY, Leiter LA.

    Curr Diab Rep. 2009 Feb;9(1):65-72.PMID: 19192427 [PubMed - indexed for MEDLINE]Related articles

    10.

    Viscosity of fiber preloads affects food intake in adolescents.

    Vuksan V, Panahi S, Lyon M, Rogovik AL, Jenkins AL, Leiter LA.

    Nutr Metab Cardiovasc Dis. 2009 Sep;19(7):498-503. Epub 2009 Jan 21.PMID: 19157816 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial.

    Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, Vidgen E, Josse AR, Nguyen TH, Corrigan S, Banach MS, Ares S, Mitchell S, Emam A, Augustin LS, Parker TL, Leiter LA.

    JAMA. 2008 Dec 17;300(23):2742-53.PMID: 19088352 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Nutritional considerations for older adults with type 2 diabetes.

    Josse AR, Panahi S, Esfahani A, Leiter LA, Jenkins DJ, Kendall CW.

    J Nutr Elder. 2008;27(3-4):363-80. Review.PMID: 19042580 [PubMed - indexed for MEDLINE]Related articles

    13.

    Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST.

    Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Egido J; ACTFAST investigators.

    Kidney Int Suppl. 2008 Dec;(111):S60-3.PMID: 19034329 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.

    Leiter LA, Bays H, Conard S, Bird S, Rubino J, Hanson ME, Tomassini JE, Tershakovec AM.

    Am J Cardiol. 2008 Dec 1;102(11):1495-501. Epub 2008 Oct 23.PMID: 19026303 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.

    Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM.

    Am J Cardiol. 2008 Dec 1;102(11):1489-94. Epub 2008 Oct 23.PMID: 19026302 [PubMed - indexed for MEDLINE]Related articles

    16.

    The effect of strawberries in a cholesterol-lowering dietary portfolio.

    Jenkins DJ, Nguyen TH, Kendall CW, Faulkner DA, Bashyam B, Kim IJ, Ireland C, Patel D, Vidgen E, Josse AR, Sesso HD, Burton-Freeman B, Josse RG, Leiter LA, Singer W.

    Metabolism. 2008 Dec;57(12):1636-44.PMID: 19013285 [PubMed - indexed for MEDLINE]Related articles

    17.

    Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.

    Tsang JL, Mendelsohn A, Tan MK, Hackam DG, Leiter LA, Fitchett D, Lin PJ, Grima E, Langer A, Goodman SG; Vascular Protection Registry and Guidelines Oriented Approach to Lipid Lowering Registry Investigators.

    Am J Cardiol. 2008 Nov 1;102(9):1142-5. Epub 2008 Aug 15.PMID: 18940280 [PubMed - indexed for MEDLINE]Related articles

    18.

    How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.

    Leiter LA, Martineau P, de Teresa E, Farsang C, Gaw A, Gensini G, Langer A; ACTFAST 1 & 2 investigators.

    J Fam Pract. 2008 Oct;57(10):661-8.PMID: 18842192 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: a multicenter, randomized, double-blind clinical trial.

    Braga MF, Grace MG, Lenis J, Kennedy FP, Teplinsky AL, Roederer G, Palumbo PJ, Colin P, Leiter LA.

    Atherosclerosis. 2009 Apr;203(2):479-82. Epub 2008 Aug 12.PMID: 18801487 [PubMed - indexed for MEDLINE]Related articles

    20.

    Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial.

    Wolever TM, Mehling C, Chiasson JL, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

    Diabetologia. 2008 Sep;51(9):1607-15. Epub 2008 Jul 22.PMID: 18648764 [PubMed - indexed for MEDLINE]Related articles

    21.

    The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

    Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program.

    Can J Cardiol. 2008 Jun;24(6):465-75. Review.PMID: 18548143 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    How many cardiovascular events can be prevented with optimal management of high-risk Canadians?

    Grima DT, Leiter LA, Goodman SG, Attard CL, Chow CM, Langer A.

    Can J Cardiol. 2008 May;24(5):363-8.PMID: 18464939 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.

    Blanco-Colio LM, Martín-Ventura JL, Gómez-Guerrero C, Masramon X, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Egido J.

    Eur J Pharmacol. 2008 May 31;586(1-3):259-65. Epub 2008 Feb 26.PMID: 18374327 [PubMed - indexed for MEDLINE]Related articles

    24.

    The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

    Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

    Am J Clin Nutr. 2008 Jan;87(1):114-25.PMID: 18175744 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Effect of plant sterols in combination with other cholesterol-lowering foods.

    Jenkins DJ, Kendall CW, Nguyen TH, Marchie A, Faulkner DA, Ireland C, Josse AR, Vidgen E, Trautwein EA, Lapsley KG, Holmes C, Josse RG, Leiter LA, Connelly PW, Singer W.

    Metabolism. 2008 Jan;57(1):130-9.PMID: 18078870 [PubMed - indexed for MEDLINE]Related articles

    26.

    Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals.

    Dascalu A, Sievenpiper JL, Jenkins AL, Stavro MP, Leiter LA, Arnason JT, Vuksan V.

    Can J Physiol Pharmacol. 2007 Sep;85(9):856-64.PMID: 18066131 [PubMed - indexed for MEDLINE]Related articles

    27.

    Missed opportunities for the secondary prevention of cardiovascular disease in Canada.

    Hackam DG, Leiter LA, Yan AT, Yan RT, Mendelsohn A, Tan M, Zavodni L, Chen R, Tsang JL, Kundi A, Lin PJ, Fitchett DH, Langer A, Goodman SG; Vascular Protection Registry and Guideline Oriented Appraoch to Lipid Lowering Registry Investigators.

    Can J Cardiol. 2007 Dec;23(14):1124-30.PMID: 18060097 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Type 2 diabetes--treat early, treat intensively.

    Goldstein BJ, Gomis R, Lee HK, Leiter LA; Global Partnership for Effective Diabetes Management.

    Int J Clin Pract Suppl. 2007 Dec;(157):16-21. Review.PMID: 17991187 [PubMed - indexed for MEDLINE]Related articles

    29.

    Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations.

    Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A.

    Am J Clin Nutr. 2007 Sep;86(3):768-74.PMID: 17823444 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

    McIntyre RS, Soczynska JK, Woldeyohannes HO, Lewis GF, Leiter LA, MacQueen GM, Miranda A, Fulgosi D, Konarski JZ, Kennedy SH.

    Expert Opin Pharmacother. 2007 Aug;8(11):1615-28. Review.PMID: 17685880 [PubMed - indexed for MEDLINE]Related articles

    31.

    Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

    Ginsberg HN, Bonds DE, Lovato LC, Crouse JR, Elam MB, Linz PE, O'connor PJ, Leiter LA, Weiss D, Lipkin E, Fleg JL; ACCORD Study Group.

    Am J Cardiol. 2007 Jun 18;99(12A):56i-67i. Epub 2007 Apr 12.PMID: 17599426 [PubMed - indexed for MEDLINE]Related articles

    32.

    Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.

    Erhardt LR, Leiter LA, Hobbs FD.

    Atherosclerosis. 2008 Feb;196(2):532-41. Epub 2007 Jul 2. Review.PMID: 17606265 [PubMed - indexed for MEDLINE]Related articles

    33.

    Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients.

    Jordan J, Greenway FL, Leiter LA, Li Z, Jacobson P, Murphy K, Hill J, Kler L, Aftring RP.

    Clin Pharmacol Ther. 2008 Feb;83(2):281-7. Epub 2007 Jun 27.PMID: 17597711 [PubMed - indexed for MEDLINE]Related articles

    34.

    PPAR-alpha: therapeutic role in diabetes-related cardiovascular disease.

    Cheng AY, Leiter LA.

    Diabetes Obes Metab. 2008 Sep;10(9):691-8. Epub 2007 Jun 26. Review.PMID: 17593234 [PubMed - indexed for MEDLINE]Related articles

    35.

    The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

    Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

    Can J Cardiol. 2007 May 15;23(7):539-50.PMID: 17534460 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Long-term effects of a plant-based dietary portfolio of cholesterol-lowering foods on blood pressure.

    Jenkins DJ, Kendall CW, Faulkner DA, Kemp T, Marchie A, Nguyen TH, Wong JM, de Souza R, Emam A, Vidgen E, Trautwein EA, Lapsley KG, Josse RG, Leiter LA, Singer W.

    Eur J Clin Nutr. 2008 Jun;62(6):781-8. Epub 2007 Apr 25.PMID: 17457340 [PubMed - indexed for MEDLINE]Related articles

    37.

    Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.

    Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Egido J; ACTFAST investigators.

    Am Heart J. 2007 May;153(5):881-8.PMID: 17452168 [PubMed - indexed for MEDLINE]Related articles

    38.

    Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.

    Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, El-Sohemy A.

    Metabolism. 2007 May;56(5):649-55.PMID: 17445540 [PubMed - indexed for MEDLINE]Related articles

    39.

    Should you put all diabetic patients on statins?

    Leiter LA.

    J Fam Pract. 2007 Apr;56(4):294-300. Review. No abstract available. PMID: 17403328 [PubMed - indexed for MEDLINE]Related articles

    40.

    Ongoing clinical trials of the pleiotropic effects of statins.

    Davignon J, Leiter LA.

    Vasc Health Risk Manag. 2005;1(1):29-40. Review.PMID: 17319096 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.

    Leiter LA, Rosenson RS, Stein E, Reckless JP, Schulte KL, Schleman M, Miller P, Palmer M, Sosef F; POLARIS study investigators.

    Atherosclerosis. 2007 Oct;194(2):e154-64. Epub 2007 Jan 16.PMID: 17229426 [PubMed - indexed for MEDLINE]Related articles

    42.

    From hyperglycemia to the risk of cardiovascular disease.

    Leiter LA.

    Rev Cardiovasc Med. 2006;7 Suppl 2:S3-9. Review.PMID: 17224875 [PubMed - indexed for MEDLINE]Related articles

    43.

    Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet.

    Jenkins DJ, Kendall CW, Nguyen TH, Teitel J, Marchie A, Chiu M, Taha AY, Faulkner DA, Kemp T, Wong JM, de Souza R, Emam A, Trautwein EA, Lapsley KG, Holmes C, Josse RG, Leiter LA, Singer W.

    Eur J Clin Nutr. 2007 Apr;61(4):483-92. Epub 2006 Nov 29.PMID: 17136042 [PubMed - indexed for MEDLINE]Related articles

    44.

    Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST.

    Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Hérnandez G, Egido J; ACTFAST investigators.

    Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):168-74. Epub 2006 Oct 19.PMID: 17053166 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patients.

    Fitchett DH, Leiter LA, Goodman SG, Langer A.

    Can J Cardiol. 2006 Aug;22(10):835-9. Review.PMID: 16957800 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    The Editor's roundtable: diabetes mellitus and coronary heart disease.

    Friedewald VE, Leiter LA, McGuire DK, Nesto RW, Roberts WC.

    Am J Cardiol. 2006 Sep 15;98(6):842-56. Epub 2006 Jul 24. No abstract available. PMID: 16950200 [PubMed - indexed for MEDLINE]Related articles

    47.

    Contemporary management of dyslipidemia in high-risk patients: targets still not met.

    Yan AT, Yan RT, Tan M, Hackam DG, Leblanc KL, Kertland H, Tsang JL, Jaffer S, Kates ML, Leiter LA, Fitchett DH, Langer A, Goodman SG; Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators.

    Am J Med. 2006 Aug;119(8):676-83.PMID: 16887414 [PubMed - indexed for MEDLINE]Related articles

    48.

    Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.

    Al-Omran M, Lindsay TF, Major J, Jawas A, Leiter LA, Verma S; Systematic Assessment of Vascular Risk Investigators.

    Ann Vasc Surg. 2006 Sep;20(5):555-63.PMID: 16871436 [PubMed - indexed for MEDLINE]Related articles

    49.

    Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.

    Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):46-56. Epub 2006 Jul 24.PMID: 16860976 [PubMed - indexed for MEDLINE]Related articles

    50.

    Can thiazolidinediones delay disease progression in type 2 diabetes?

    Leiter LA.

    Curr Med Res Opin. 2006 Jun;22(6):1193-201. Review.PMID: 16846552 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...